The pentanucleotide regression (Fig 2B) finds enrichment of pyrimidines at position -2, supporting the role of the APOBEC3A enzyme [50] rather than the APOBEC3B paralog in mutagenizing this particular tumor. The gene discussed is APOBEC3A; the disease is neoplasm.